Avastin Biosimilar Meets Phase III Endpoints, Demonstrating Clinical Equivalence in Lung Cancer October 01, 2015Vol.38 No.09
Drugs & Targets European Commission Approves Unituxin In Pediatric High-Risk Neuroblastoma August 31, 2015Vol.38 No.08
Oral Telotristat Etiprate Meets Primary Endpoint in Phase III Carcinoid Syndrome Trial August 31, 2015Vol.38 No.08
Atezolizumab Immunotherapy Meets Response Endpoint in Phase II NSCLC Study August 31, 2015Vol.38 No.08
Study: Robotic Surgery Shows Long-term Results Similar to Traditional Open Surgery in Bladder Cancer August 04, 2015Vol.38 No.07
